Shusuke Kawashima

5PUBLICATIONS
39CO-AUTHORS
Molecular targetsTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 11, 2026
Phenotypic Analysis of 26 Cultured TILs Derived From Japanese Melanoma Tissues.

|Jul 31, 2025
PI3K/Akt Signaling Pathway Regulates CD155 Expression Involved in Resistance to Cancer Immunotherapy.

Katsushige Kawase, Shusuke Kawashima, Tatsuya Nishi

|Aug 21, 2024
Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunity.

Fumiaki Mukohara, Kazuma Iwata, Takamasa Ishino

|Apr 18, 2024
CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling.

Yuto Naoi, Takao Morinaga, Joji Nagasaki

|Apr 16, 2023
High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects.

Katsushige Kawase, Shusuke Kawashima, Joji Nagasaki

Pageof 1

Frequent Collaborators

5 joint publications

Katsushige Kawase

5 joint publications

Takashi Inozume

4 joint publications

Masahito Kawazu

4 joint publications

Yosuke Togashi